Opportunities Preloader

Please Wait.....

Report

Single Cell Analysis Market by Product (Consumables (Beads, Kits, Reagents), Instruments), Cell Type (Human, Animal), Technique (Flow Cytometry, NGS, PCR, Microscopy), Application (Research (Cancer, Neurology), Medical (NIPT, IVF)) - Global Forecast to 2030

Market Report I 2025-05-07 I 518 Pages I MarketsandMarkets

The single-cell analysis market is projected to reach USD 7.56 billion by 2030 from an estimated USD 3.81 billion in 2025, at a CAGR of 14.7% during the forecast period. This market growth is largely driven by the increasing emphasis on personalized medicine. Rising research & development investments in the pharmaceutical and biotechnology industries also contribute to the expansion of single-cell analysis. Additionally, factors such as growth in stem cell research and advancements in single-cell analysis technologies are expected to further boost the market. Furthermore, the increasing incidence of cancer is creating a demand for advanced therapies, which is anticipated to enhance the growth of the single-cell analysis market. The rising adoption of advanced single-cell sequencing techniques is also expected to propel market growth in the coming years.
"The research applications segment accounted for the largest share of the market segment in 2024."
The single-cell analysis market is divided into two main categories based on applications: research and medical applications. The research application segment includes various fields such as cancer research, immunology research, neurology research, stem cell research, and other related areas. In contrast, the medical applications segment is further divided into non-invasive prenatal diagnosis, in vitro fertilization, and circulating tumor cell detection.
In 2024, the research applications segment held the largest share of the global single-cell analysis market. The increasing prevalence of cancer is driving the demand for advanced therapies, which contributes to the growth of this segment. Additionally, the expansion of stem cell research is also expected to further boost the growth of the single-cell analysis market.
"The flow cytometry segment accounted for a major share of the market in 2024."
The single-cell analysis market is categorized based on technology into several segments: flow cytometry, next-generation sequencing, polymerase chain reaction, microscopy, mass spectrometry, and other techniques. In 2024, the flow cytometry segment was the largest contributor to the global single-cell analysis market by technology. This significant growth is primarily due to the widespread use of flow cytometry in single-cell analysis, as it can perform multiple measurements within a heterogeneous mixture. Furthermore, the increasing adoption of advanced cell identification and characterization technologies is expected to further drive growth in this segment of the single-cell analysis market.

"The US dominated the single-cell analysis market in 2024."
The single-cell analysis market is divided into six major regions: North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. In 2024, the US dominated this market in North America. As the world's largest biopharmaceutical market, the US leads in biopharmaceutical research and investments. Its robust healthcare infrastructure further supports research & development in the life sciences sector. Additionally, the presence of numerous biopharmaceutical companies and increasing research activities in the biotechnology industry are contributing to market growth in the US. Furthermore, the rising focus on developing personalized medicine, driven by the increasing incidence of cancer, is also boosting the growth of the single-cell analysis market.

The primary interviews conducted for this report can be categorized as follows:

- By Respondent: Supply Side (70%) and Demand Side (30%)
- By Designation: Managers (45%), CXOs & Directors (30%), and Executives (25%)
- By Region: North America (40%), Europe (25%), Asia Pacific (25%), Latin America (5%), and Middle East & Africa (5%)
List of Companies Profiled in the Report:

- Thermo Fisher Scientific Inc. (US)
- Danaher Corporation (US)
- Merck KGaA (Germany)
- BD (US)
- Agilent Technologies, Inc. (US)
- QIAGEN (Netherlands)
- 10x Genomics (US)
- Illumina, Inc. (US)
- Bio-Rad Laboratories, Inc. (US)
- DiaSorin S.p.A. (Italy)
- Standard BioTools (US)
- Tecan Trading AG (Switzerland)
- Sartorius AG (Germany)
- Corning Incorporated (US)
- Cytek Biosciences (US)
- Takara Bio Inc. (Japan)
- bioMerieux (France)
- Revvity (US)
- Bio-Techne (US)
- PacBio (US)
- Bruker (US)
- Promega Corporation (US)
- Oxford Nanopore Technologies plc. (UK)
- The Menarini Group (Italy)
- Singleron Biotechnologies (Germany)
- BICO (Sweden)
- Fluent BioSciences (US)
- RareCyte, Inc. (US)
- Cell Microsystems (US)
- NanoCellect Biomedical (US)
- Apogee Flow Systems Ltd. (UK)
- Creative Biolabs (US)
- Sphere Bio (UK)
- Yokogawa Electric Corporation (Japan)

Research Coverage:
This research report categorizes the single-cell analysis market by product {consumables [reagents, assay kits (immunoassays and cell-based assays), beads, microplates, and other consumables] and instruments (PCR instruments, NGS systems, flow cytometers, spectrophotometers, cell counters, microscopes, HCS systems, microarrays, and other instruments)}, cell type (human cells, animal cells, and microbial cells), technique (flow cytometry, next-generation sequencing, microscopy, polymerase chain reaction, mass spectrometry, and other techniques), application [research applications (cancer research, immunology research, neurology research, stem cell research, and other research applications) and medical applications (non-invasive prenatal diagnosis, in vitro fertilization, and circulating tumour cell detection)], end user (academic & research laboratories, biotechnology & pharmaceutical companies, hospitals & diagnostic laboratories, and cell banks & IVF centers), and region (North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the single-cell analysis market. A thorough analysis of the key industry players has been done to provide insights into their business overview, products, key strategies, collaborations, partnerships, and agreements. Also, it includes new product launches, collaborations, acquisitions, and recent developments associated with the single-cell analysis market.
Key Benefits of Buying the Report:
The report will help market leaders and new entrants by providing the closest approximations of the revenue numbers for the overall single-cell analysis market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their businesses and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
- Analysis of key drivers (technological advancements in single-cell analysis products, the surge in cases of cancer, and increasing R&D in pharmaceutical & biotechnology industries for complex diseases), restraints (high cost of single-cell analysis products), opportunities (integration of microfluidics in single-cell analysis), and challenges (standardization of protocols and data integration & quality control for developing cell therapies) influencing the growth of the market
- Product Development/Innovation: Detailed insights on newly launched products of the single-cell analysis market
- Market Development: Comprehensive information about lucrative markets; the report analyzes the market across varied regions
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the single-cell analysis market
- Competitive Assessment: Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Merck KGaA (Germany), BD (US), Agilent Technologies, Inc. (US), QIAGEN (Netherlands), 10x Genomics (US), Illumina, Inc. (US), Bio-Rad Laboratories, Inc. (US), DiaSorin S.p.A. (Italy), Standard BioTools (US), Tecan Trading AG (Switzerland), Sartorius AG (Germany), Corning Incorporated (US), Cytek Biosciences (US), Takara Bio Inc. (Japan), bioMerieux (France), Revvity (US), Bio-Techne (US), PacBio (US), Bruker (US), Promega Corporation (US), Oxford Nanopore Technologies plc. (UK), The Menarini Group (Italy), Singleron Biotechnologies (Germany), BICO (Sweden), Fluent BioSciences (US), RareCyte, Inc. (US), Cell Microsystems (US), NanoCellect Biomedical (US), Apogee Flow Systems Ltd. (UK), Creative Biolabs (US) Sphere Bio (UK), and Yokogawa Electric Corporation (Japan)

1 INTRODUCTION 47
1.1 STUDY OBJECTIVES 47
1.2 MARKET DEFINITION 47
1.3 STUDY SCOPE 47
1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE 48
1.3.2 YEARS CONSIDERED 49
1.3.3 INCLUSIONS AND EXCLUSIONS 49
1.4 CURRENCY CONSIDERED 50
1.5 STAKEHOLDERS 51
1.6 SUMMARY OF CHANGES 51
2 RESEARCH METHODOLOGY 52
2.1 RESEARCH DATA 52
2.1.1 SECONDARY DATA 53
2.1.2 PRIMARY DATA 53
2.2 MARKET SIZE ESTIMATION METHODOLOGY 55
2.2.1 GLOBAL SINGLE-CELL ANALYSIS MARKET SIZE ESTIMATION 55
2.2.2 INSIGHTS FROM PRIMARY EXPERTS 57
2.2.3 TOP-DOWN APPROACH 58
2.3 MARKET GROWTH RATE PROJECTIONS 59
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 61
2.5 RESEARCH ASSUMPTIONS 62
2.6 RISK ANALYSIS 62
2.7 RESEARCH LIMITATIONS 62
3 EXECUTIVE SUMMARY 64
4 PREMIUM INSIGHTS 68
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN SINGLE-CELL ANALYSIS MARKET 68
4.2 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE AND COUNTRY 69
4.3 SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2025 VS. 2030 69
4.4 SINGLE-CELL ANALYSIS MARKET, BY END USER 70
4.5 SINGLE-CELL ANALYSIS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 70
?
5 MARKET OVERVIEW 71
5.1 INTRODUCTION 71
5.2 MARKET DYNAMICS 71
5.2.1 DRIVERS 73
5.2.1.1 Technological advancements in single-cell analysis products 73
5.2.1.2 Rising prevalence of cancer 74
5.2.1.3 Increasing R&D in pharmaceutical and biotechnology industries 75
5.2.1.4 Growth in stem cell research 76
5.2.1.5 Growing focus on personalized medicine 78
5.2.2 RESTRAINTS 79
5.2.2.1 High cost of single-cell analysis products 79
5.2.3 OPPORTUNITIES 80
5.2.3.1 High growth potential of single-cell sequencing 80
5.2.3.2 Integration of microfluidics in single-cell analysis 80
5.2.3.3 Rising potential in emerging Asian markets 81
5.2.4 CHALLENGES 81
5.2.4.1 Lack of standardization in protocols and quality control procedures 81
5.2.4.2 Technical limitations of single-cell analysis 82
5.2.4.3 Mounting ethical and privacy concerns 82
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 82
5.4 VALUE CHAIN ANALYSIS 83
5.5 ECOSYSTEM ANALYSIS 85
5.6 TECHNOLOGY ANALYSIS 88
5.6.1 KEY TECHNOLOGIES 88
5.6.1.1 Flow cytometry 88
5.6.1.2 Next-generation sequencing 88
5.6.1.3 Polymerase chain reaction 89
5.6.1.4 Microscopy 89
5.6.1.5 Mass spectrometry 90
5.6.2 COMPLEMENTARY TECHNOLOGIES 90
5.6.2.1 Bioinformatics tools and computational analysis 90
5.6.2.2 Multi-omics integration 91
5.6.3 ADJACENT TECHNOLOGIES 92
5.6.3.1 Nanotechnology 92
5.6.3.2 Artificial intelligence and machine learning 92
5.7 PATENT ANALYSIS 92
5.7.1 METHODOLOGY 92
5.7.2 PATENTS APPLIED AND GRANTED, 2014-2024 92
?
5.8 TRADE ANALYSIS 95
5.8.1 IMPORT DATA (HS CODE 9027) 95
5.8.2 EXPORT DATA (HS CODE 9027) 97
5.9 PORTER'S FIVE FORCES ANALYSIS 99
5.9.1 THREAT OF NEW ENTRANTS 100
5.9.2 THREAT OF SUBSTITUTES 100
5.9.3 BARGAINING POWER OF SUPPLIERS 100
5.9.4 BARGAINING POWER OF BUYERS 100
5.9.5 INTENSITY OF COMPETITIVE RIVALRY 101
5.10 TARIFF & REGULATORY LANDSCAPE 101
5.10.1 TARIFF DATA (HS CODE 9027) 101
5.10.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 102
5.10.3 REGULATORY FRAMEWORK 105
5.11 PRICING ANALYSIS 108
5.11.1 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY KEY PLAYERS 108
5.11.2 AVERAGE SELLING PRICE OF PRODUCTS, BY REGION 108
5.12 KEY CONFERENCES AND EVENTS, 2025-2026 109
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA 110
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 110
5.13.2 ROLE OF STAKEHOLDERS IN BUYING PROCESS 110
5.13.3 BUYING CRITERIA 111
5.14 INVESTMENT AND FUNDING SCENARIO 112
5.15 IMPACT OF GENERATIVE AI ON SINGLE-CELL ANALYSIS MARKET 113
5.15.1 AI USE-CASES 114
5.15.2 KEY COMPANIES IMPLEMENTING AI 115
5.16 CASE STUDY ANALYSIS 115
5.16.1 COMPREHENSIVE SINGLE?CELL TRANSCRIPTOMIC ATLAS OF HUMAN CORNEA 115
5.16.2 MASSIVELY PARALLEL SINGLE-CELL RNA SEQUENCING IDENTIFIES RARE DRUG-RESISTANT CANCER SUBPOPULATIONS 115
5.16.3 SINGLE-CELL ANALYSIS OF RENAL CELL CARCINOMA REVEALS TUMOR HETEROGENEITY AND MICROENVIRONMENTAL COMPLEXITY 116
5.17 US 2025 TARIFF IMPACT OVERVIEW 116
5.17.1 INTRODUCTION 116
5.17.2 KEY TARIFF RATES 117
5.17.3 PRICE IMPACT ANALYSIS 118
5.17.4 KEY IMPACT ON VARIOUS REGIONS 119
5.17.4.1 US 119
5.17.4.2 Europe 119
5.17.4.3 Asia Pacific 119
5.17.4.4 Rest of the World 120
5.17.5 END-USE INDUSTRY IMPACT 120
5.17.5.1 Pharmaceutical and biotech companies 120
5.17.5.2 Contract research organizations (CROs) 120
5.17.5.3 Academic & research institutes 121
6 SINGLE-CELL ANALYSIS MARKET, BY APPLICATION 122
6.1 INTRODUCTION 123
6.2 RESEARCH APPLICATIONS 123
6.2.1 CANCER RESEARCH 127
6.2.1.1 Rising prevalence of cancer to drive market 127
6.2.2 IMMUNOLOGY RESEARCH 130
6.2.2.1 High incidence of immunological disorders to propel market 130
6.2.3 NEUROLOGY RESEARCH 133
6.2.3.1 Increasing incidence of neurological disorders to boost market 133
6.2.4 STEM CELL RESEARCH 136
6.2.4.1 Rising investments in stem cell research to drive market 136
6.2.5 OTHER RESEARCH APPLICATIONS 139
6.3 MEDICAL APPLICATIONS 142
6.3.1 NON-INVASIVE PRENATAL DIAGNOSIS 145
6.3.1.1 Increasing prevalence of genetic diseases to drive demand 145
6.3.2 IN VITRO FERTILIZATION 149
6.3.2.1 Growing demand for IVF procedures to support market 149
6.3.3 CIRCULATING TUMOR CELL DETECTION 152
6.3.3.1 Rising prevalence of cancer to contribute to segment growth 152
7 SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE 155
7.1 INTRODUCTION 156
7.2 HUMAN CELLS 156
7.2.1 GROWING FUNDING FOR CANCER RESEARCH TO BOOST DEMAND 156
7.3 ANIMAL CELLS 159
7.3.1 INCREASING ANIMAL CELL RESEARCH TO DRIVE MARKET 159
7.4 MICROBIAL CELLS 162
7.4.1 RISING GOVERNMENT SUPPORT TO COMBAT ANTIMICROBIAL RESISTANCE TO PROPEL MARKET 162
8 SINGLE-CELL ANALYSIS MARKET, BY END USER 166
8.1 INTRODUCTION 167
8.2 ACADEMIC & RESEARCH LABORATORIES 167
8.2.1 INCREASING FUNDING FOR LIFE SCIENCE RESEARCH TO DRIVE MARKET 167
8.3 BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES 171
8.3.1 GROWTH IN DRUG DISCOVERY AND R&D ACTIVITIES TO BOOST MARKET 171
8.4 HOSPITALS & DIAGNOSTIC LABORATORIES 174
8.4.1 HIGH PREVALENCE OF INFECTIOUS AND CHRONIC DISEASES TO DRIVE DEMAND 174
8.5 CELL BANKS & IVF CENTERS 178
8.5.1 RISING DEMAND FOR PERSONALIZED AND REGENERATIVE MEDICINE TO PROPEL MARKET 178
9 SINGLE-CELL ANALYSIS MARKET, BY PRODUCT 182
9.1 INTRODUCTION 183
9.2 CONSUMABLES 183
9.2.1 BEADS 186
9.2.1.1 Increasing use in research and genetic exploration to drive market 186
9.2.2 MICROPLATES 189
9.2.2.1 Rising frequency of product launches to boost market 189
9.2.3 REAGENTS 192
9.2.3.1 Advancements in single-cell genomics to increase demand 192
9.2.4 ASSAY KITS 195
9.2.4.1 Immunoassays 198
9.2.4.1.1 Growth in geriatric population to fuel demand 198
9.2.4.2 Cell-based assays 200
9.2.4.2.1 Increasing use in pharma and biopharma companies to drive market 200
9.2.5 OTHER CONSUMABLES 203
9.3 INSTRUMENTS 206
9.3.1 FLOW CYTOMETERS 209
9.3.1.1 Technological advancements to drive demand 209
9.3.2 NGS SYSTEMS 213
9.3.2.1 Increased affordability to support segment growth 213
9.3.3 PCR INSTRUMENTS 216
9.3.3.1 Rising use for DNA and mRNA amplification to boost market 216
9.3.4 SPECTROPHOTOMETERS 218
9.3.4.1 Technological advancements to boost market 218
9.3.5 CELL COUNTERS 221
9.3.5.1 Rising demand for automated cell counters to fuel market 221
9.3.6 MICROSCOPES 224
9.3.6.1 Increasing use in cell-based research to drive market 224
9.3.7 HCS SYSTEMS 227
9.3.7.1 Growing need for multi-parametric cell analysis to drive adoption 227
9.3.8 MICROARRAYS 229
9.3.8.1 Increasing development of targeted therapies to support market 229
9.3.9 OTHER INSTRUMENTS 232
?
10 SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE 236
10.1 INTRODUCTION 237
10.2 FLOW CYTOMETRY 237
10.2.1 INCREASING USE TO IDENTIFY CANCEROUS CELLS TO DRIVE MARKET 237
10.3 NEXT-GENERATION SEQUENCING 241
10.3.1 WIDE ADOPTION IN DRUG DISCOVERY TO DRIVE MARKET 241
10.4 POLYMERASE CHAIN REACTION 244
10.4.1 INCREASING APPLICATIONS OF DIGITAL PCR TO SUPPORT MARKET 244
10.5 MICROSCOPY 247
10.5.1 FOCUS ON DEVELOPMENT OF ADVANCED IMAGING SYSTEMS TO PROPEL MARKET 247
10.6 MASS SPECTROMETRY 250
10.6.1 LAUNCH OF ADVANCED PRODUCTS TO DRIVE MARKET 250
10.7 OTHER TECHNIQUES 253
11 SINGLE-CELL ANALYSIS MARKET, BY REGION 257
11.1 INTRODUCTION 258
11.2 NORTH AMERICA 258
11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 263
11.2.2 US 264
11.2.2.1 Increasing R&D investments and funding to drive market 264
11.2.3 CANADA 269
11.2.3.1 High prevalence of hemophilia to propel market 269
11.3 EUROPE 273
11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 277
11.3.2 GERMANY 278
11.3.2.1 Growing awareness of advanced cell therapies to support market 278
11.3.3 UK 282
11.3.3.1 Growing adoption of single-cell analysis products to drive demand 282
11.3.4 FRANCE 286
11.3.4.1 Growing government funding for R&D to propel market 286
11.3.5 ITALY 290
11.3.5.1 Focus on cell biology research to drive market 290
11.3.6 SPAIN 294
11.3.6.1 Increasing number of biotechnology companies to drive demand 294
11.3.7 REST OF EUROPE 298
11.4 ASIA PACIFIC 303
11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 308
11.4.2 CHINA 309
11.4.2.1 Increasing R&D expenditure to support market 309
11.4.3 JAPAN 313
11.4.3.1 Increasing geriatric population to fuel demand 313
11.4.4 INDIA 317
11.4.4.1 Growing focus on development of cell-based therapies to boost market 317
11.4.5 SOUTH KOREA 321
11.4.5.1 Increasing number of strategic alliances to boost market 321
11.4.6 AUSTRALIA 325
11.4.6.1 Rising number of life science companies to boost demand 325
11.4.7 REST OF ASIA PACIFIC 329
11.5 LATIN AMERICA 333
11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 337
11.5.2 BRAZIL 338
11.5.2.1 Rising focus on biotechnology industry to bolster market 338
11.5.3 MEXICO 342
11.5.3.1 Government support for biopharmaceutical production to drive market 342
11.5.4 REST OF LATIN AMERICA 346
11.6 MIDDLE EAST 350
11.6.1 MACROECONOMIC OUTLOOK IN MIDDLE EAST 354
11.6.2 GCC 355
11.6.2.1 Saudi Arabia 359
11.6.2.1.1 Increasing healthcare expenditure to drive market 359
11.6.2.2 United Arab Emirates 363
11.6.2.2.1 Advancements in biopharmaceutical sector to drive demand 363
11.6.2.3 Rest of GCC 367
11.6.3 REST OF MIDDLE EAST 371
11.7 AFRICA 375
11.7.1 GROWING FUNDING FOR DEVELOPMENT AND PRODUCTION OF BIOPHARMACEUTICALS TO DRIVE MARKET 375
11.7.2 MACROECONOMIC OUTLOOK FOR AFRICA 379
12 COMPETITIVE LANDSCAPE 381
12.1 OVERVIEW 381
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2021-2025 381
12.3 REVENUE ANALYSIS, 2022-2024 386
12.4 MARKET SHARE ANALYSIS, 2024 387
12.4.1 RANKING OF KEY MARKET PLAYERS 389
12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 389
12.5.1 STARS 389
12.5.2 EMERGING LEADERS 389
12.5.3 PERVASIVE PLAYERS 390
12.5.4 PARTICIPANTS 390
12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 391
12.5.5.1 Company footprint 391
12.5.5.2 Product footprint 392
12.5.5.3 Region footprint 393
12.5.5.4 Technique footprint 394
12.5.5.5 Application footprint 395
12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 396
12.6.1 PROGRESSIVE COMPANIES 396
12.6.2 RESPONSIVE COMPANIES 396
12.6.3 DYNAMIC COMPANIES 396
12.6.4 STARTING BLOCKS 396
12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 398
12.6.5.1 Detailed list of key startups/SMEs 398
12.6.5.2 Competitive benchmarking of key startups/SMEs 399
12.7 COMPANY VALUATION AND FINANCIAL METRICS 400
12.8 BRAND/PRODUCT COMPARISON 401
12.9 COMPETITIVE SCENARIO 403
12.9.1 PRODUCT LAUNCHES 403
12.9.2 DEALS 405
12.9.3 EXPANSIONS 407
13 COMPANY PROFILES 408
13.1 INTRODUCTION 408
13.2 KEY PLAYERS 408
13.2.1 BD 408
13.2.1.1 Business overview 408
13.2.1.2 Products offered 409
13.2.1.3 Recent developments 411
13.2.1.3.1 Product launches 411
13.2.1.3.2 Deals 412
13.2.1.4 MnM view 412
13.2.1.4.1 Key strengths 412
13.2.1.4.2 Strategic choices 413
13.2.1.4.3 Weaknesses and competitive threats 413
13.2.2 THERMO FISHER SCIENTIFIC INC. 414
13.2.2.1 Business overview 414
13.2.2.2 Products offered 415
13.2.2.3 Recent developments 418
13.2.2.3.1 Product launches 418
13.2.2.3.2 Deals 418
13.2.2.4 MnM view 419
13.2.2.4.1 Key strengths 419
13.2.2.4.2 Strategic choices 419
13.2.2.4.3 Weaknesses and competitive threats 419
13.2.3 DANAHER CORPORATION 420
13.2.3.1 Business overview 420
13.2.3.2 Products offered 421
13.2.3.3 Recent developments 423
13.2.3.3.1 Deals 423
13.2.3.4 MnM view 424
13.2.3.4.1 Key strengths 424
13.2.3.4.2 Strategic choices 424
13.2.3.4.3 Weaknesses and competitive threats 424
13.2.4 10X GENOMICS 425
13.2.4.1 Business overview 425
13.2.4.2 Products offered 427
13.2.4.3 Recent developments 428
13.2.4.3.1 Product launches 428
13.2.4.3.2 Deals 429
13.2.5 MERCK KGAA 431
13.2.5.1 Business overview 431
13.2.5.2 Products offered 432
13.2.5.3 Recent developments 434
13.2.5.3.1 Deals 434
13.2.6 AGILENT TECHNOLOGIES, INC. 435
13.2.6.1 Business overview 435
13.2.6.2 Products offered 436
13.2.6.3 Recent developments 438
13.2.6.3.1 Product launches 438
13.2.6.3.2 Deals 439
13.2.7 QIAGEN 440
13.2.7.1 Business overview 440
13.2.7.2 Products offered 442
13.2.7.3 Recent developments 443
13.2.7.3.1 Deals 443
13.2.8 ILLUMINA, INC. 444
13.2.8.1 Business overview 444
13.2.8.2 Products offered 445
13.2.8.3 Recent developments 447
13.2.8.3.1 Product launches 447
13.2.8.3.2 Deals 447
13.2.9 BIO-RAD LABORATORIES, INC. 449
13.2.9.1 Business overview 449
13.2.9.2 Products offered 451
13.2.9.3 Recent developments 453
13.2.9.3.1 Product launches 453
13.2.10 DIASORIN S.P.A. 454
13.2.10.1 Business overview 454
13.2.10.2 Products offered 456
13.2.10.3 Recent developments 456
13.2.10.3.1 Deals 456
13.2.11 STANDARD BIOTOOLS 457
13.2.11.1 Business overview 457
13.2.11.2 Product offered 458
13.2.11.3 Recent developments 459
13.2.11.3.1 Product launches 459
13.2.11.3.2 Deals 460
13.2.12 TECAN TRADING AG 461
13.2.12.1 Business overview 461
13.2.12.2 Products offered 462
13.2.12.3 Recent developments 463
13.2.12.3.1 Product launches 463
13.2.12.3.2 Deals 463
13.2.13 SARTORIUS AG 464
13.2.13.1 Business overview 464
13.2.13.2 Products offered 465
13.2.13.3 Recent developments 466
13.2.13.3.1 Deals 466
13.2.13.3.2 Expansions 466
13.2.14 CORNING INCORPORATED 467
13.2.14.1 Business overview 467
13.2.14.2 Products offered 468
13.2.15 CYTEK BIOSCIENCES 469
13.2.15.1 Business overview 469
13.2.15.2 Products offered 470
13.2.15.3 Recent developments 470
13.2.15.3.1 Product launches 470
13.2.15.3.2 Deals 471
13.2.15.3.3 Expansions 471
13.2.16 TAKARA BIO INC. 472
13.2.16.1 Business overview 472
13.2.16.2 Products offered 473
13.2.16.3 Recent developments 475
13.2.16.3.1 Product launches 475
13.2.16.3.2 Deals 475
?
13.2.17 BIOMERIEUX 476
13.2.17.1 Business overview 476
13.2.17.2 Products offered 477
13.2.17.3 Recent developments 478
13.2.17.3.1 Deals 478
13.2.18 REVVITY 479
13.2.18.1 Business overview 479
13.2.18.2 Products offered 480
13.2.18.3 Recent developments 482
13.2.18.3.1 Deals 482
13.2.19 BIO-TECHNE 483
13.2.19.1 Business overview 483
13.2.19.2 Products offered 484
13.2.19.3 Recent developments 485
13.2.19.3.1 Deals 485
13.2.20 PACBIO 486
13.2.20.1 Business overview 486
13.2.20.2 Products offered 487
13.2.20.3 Recent developments 487
13.2.20.3.1 Product launches 487
13.2.21 BRUKER 488
13.2.21.1 Business overview 488
13.2.21.2 Products offered 490
13.2.21.3 Recent developments 491
13.2.21.3.1 Product launches 491
13.2.21.3.2 Deals 492
13.2.22 PROMEGA CORPORATION 493
13.2.22.1 Business overview 493
13.2.22.2 Products offered 493
13.2.23 OXFORD NANOPORE TECHNOLOGIES PLC 495
13.2.23.1 Business overview 495
13.2.23.2 Products offered 496
13.2.23.3 Recent developments 497
13.2.23.3.1 Deals 497
13.3 OTHER PLAYERS 498
13.3.1 SINGLERON BIOTECHNOLOGIES 498
13.3.2 CELL MICROSYSTEMS 499
13.3.3 NANOCELLECT BIOMEDICAL 500
13.3.4 RARECYTE, INC. 501
13.3.5 BICO 502
13.3.6 MENARINI GROUP 503
13.3.7 APOGEE FLOW SYSTEMS LTD 504
13.3.8 CREATIVE BIOLABS 505
13.3.9 SPHERE BIO 506
13.3.10 YOKOGAWA ELECTRIC CORPORATION 507
14 APPENDIX 508
14.1 DISCUSSION GUIDE 508
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL 514
14.3 CUSTOMIZATION OPTIONS 516
14.4 RELATED REPORTS 516
14.5 AUTHOR DETAILS 517

TABLE 1 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS 60
TABLE 2 SINGLE-CELL ANALYSIS MARKET: IMPACT ANALYSIS 72
TABLE 3 RECENT TECHNOLOGICAL ADVANCEMENTS AND PRODUCT LAUNCHES 73
TABLE 4 PROJECTED INCREASE IN NUMBER OF CANCER PATIENTS,
2015 VS. 2018 VS. 2020 VS. 2035 74
TABLE 5 PHARMACEUTICAL R&D SPENDING, BY COMPANY, 2020 VS. 2026 (USD BILLION) 76
TABLE 6 ESTIMATED EXPENDITURE BY NIH FOR STEM CELL RESEARCH, 2019-2025 77
TABLE 7 SINGLE-CELL ANALYSIS MARKET: RAW MATERIAL VENDORS 85
TABLE 8 SINGLE-CELL ANALYSIS MARKET: PRODUCT VENDORS 86
TABLE 9 SINGLE-CELL ANALYSIS MARKET: END USERS 87
TABLE 10 SINGLE-CELL ANALYSIS MARKET: REGULATORY BODIES 87
TABLE 11 APPLICATIONS OF MICROSCOPIC TECHNIQUES IN SINGLE-CELL ANALYSIS 89
TABLE 12 TYPES OF BIOINFORMATICS TOOLS 91
TABLE 13 PATENTS FILED, 2014-2024 92
TABLE 14 INNOVATIONS AND PATENT REGISTRATIONS, 2023-2024 94
TABLE 15 IMPORT VALUE OF HS CODE 9027-COMPLIANT PRODUCTS FOR
TOP 20 COUNTRIES, 2020-2024 (USD THOUSAND) 95
TABLE 16 IMPORT VOLUME FOR HS CODE 9027-COMPLIANT PRODUCTS FOR
TOP 20 COUNTRIES, 2020-2024 (TONS) 96
TABLE 17 EXPORT VALUE OF HS CODE 9027-COMPLIANT PRODUCTS FOR
TOP 20 COUNTRIES, 2020-2024 (USD THOUSAND) 97
TABLE 18 EXPORT VOLUME FOR HS CODE 9027-COMPLIANT PRODUCTS FOR
TOP 20 COUNTRIES, 2020-2024 (TONS) 98
TABLE 19 SINGLE-CELL ANALYSIS MARKET: PORTER'S FIVE FORCES ANALYSIS 100
TABLE 20 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 102
TABLE 21 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 102
TABLE 22 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 103
TABLE 23 ROW: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 104
TABLE 24 SINGLE-CELL ANALYSIS MARKET: REGULATORY GUIDELINES 105
TABLE 25 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY KEY PLAYERS, 2022-2024 108
TABLE 26 AVERAGE SELLING PRICE OF PRODUCTS, BY REGION, 2024 108
TABLE 27 SINGLE-CELL ANALYSIS MARKET: KEY CONFERENCES AND EVENTS, 2025-2026 109
TABLE 28 BUYING CRITERIA FOR SINGLE-CELL ANALYSIS PRODUCTS, BY END USER 111
TABLE 29 US ADJUSTED RECIPROCAL TARIFF RATES 117
TABLE 30 KEY PRODUCT-RELATED TARIFF: MISCELLANEOUS CHEMICAL PRODUCTS AND ELECTRICAL MACHINERY AND EQUIPMENT AND PARTS THEREOF 118
TABLE 31 CRITICAL COMPONENTS EXPOSED TO TARIFF CHANGES 118
TABLE 32 SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION) 123
TABLE 33 SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE,
2023-2030 (USD MILLION) 124
TABLE 34 SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2023-2030 (USD MILLION) 124
TABLE 35 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION) 124
TABLE 36 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS,
BY COUNTRY, 2023-2030 (USD MILLION) 125
TABLE 37 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS,
BY COUNTRY, 2023-2030 (USD MILLION) 125
TABLE 38 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION) 126
TABLE 39 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS,
BY COUNTRY, 2023-2030 (USD MILLION) 126
TABLE 40 GCC: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS,
BY COUNTRY, 2023-2030 (USD MILLION) 126
TABLE 41 SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH, BY REGION,
2023-2030 (USD MILLION) 127
TABLE 42 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH,
BY COUNTRY, 2023-2030 (USD MILLION) 127
TABLE 43 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH, BY COUNTRY, 2023-2030 (USD MILLION) 128
TABLE 44 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH,
BY COUNTRY, 2023-2030 (USD MILLION) 128
TABLE 45 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH,
BY COUNTRY, 2023-2030 (USD MILLION) 129
TABLE 46 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH,
BY COUNTRY, 2023-2030 (USD MILLION) 129
TABLE 47 GCC: SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH, BY COUNTRY, 2023-2030 (USD MILLION) 129
TABLE 48 SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH, BY REGION, 2023-2030 (USD MILLION) 130
TABLE 49 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH, BY COUNTRY, 2023-2030 (USD MILLION) 131
TABLE 50 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH,
BY COUNTRY, 2023-2030 (USD MILLION) 131
TABLE 51 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH,
BY COUNTRY, 2023-2030 (USD MILLION) 131
TABLE 52 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH, BY COUNTRY, 2023-2030 (USD MILLION) 132
TABLE 53 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH,
BY COUNTRY, 2023-2030 (USD MILLION) 132
TABLE 54 GCC: SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH,
BY COUNTRY, 2023-2030 (USD MILLION) 132
TABLE 55 SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH, BY REGION,
2023-2030 (USD MILLION) 133
TABLE 56 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH, BY COUNTRY, 2023-2030 (USD MILLION) 134
TABLE 57 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH,
BY COUNTRY, 2023-2030 (USD MILLION) 134
TABLE 58 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH,
BY COUNTRY, 2023-2030 (USD MILLION) 134
TABLE 59 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH,
BY COUNTRY, 2023-2030 (USD MILLION) 135
TABLE 60 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH,
BY COUNTRY, 2023-2030 (USD MILLION) 135
TABLE 61 GCC: SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH, BY COUNTRY, 2023-2030 (USD MILLION) 135
TABLE 62 SINGLE-CELL ANALYSIS MARKET FOR STEM CELL RESEARCH, BY REGION,
2023-2030 (USD MILLION) 136
TABLE 63 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR STEM CELL RESEARCH,
BY COUNTRY, 2023-2030 (USD MILLION) 136
TABLE 64 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR STEM CELL RESEARCH,
BY COUNTRY, 2023-2030 (USD MILLION) 137
TABLE 65 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR STEM CELL RESEARCH,
BY COUNTRY, 2023-2030 (USD MILLION) 137
TABLE 66 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR STEM CELL RESEARCH,
BY COUNTRY, 2023-2030 (USD MILLION) 138
TABLE 67 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR STEM CELL RESEARCH,
BY COUNTRY, 2023-2030 (USD MILLION) 138
TABLE 68 GCC: SINGLE-CELL ANALYSIS MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2023-2030 (USD MILLION) 138
TABLE 69 SINGLE-CELL ANALYSIS MARKET FOR OTHER RESEARCH APPLICATIONS,
BY REGION, 2023-2030 (USD MILLION) 139
TABLE 70 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION) 139
TABLE 71 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION) 140
TABLE 72 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION) 140
TABLE 73 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION) 141
TABLE 74 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION) 141
TABLE 75 GCC: SINGLE-CELL ANALYSIS MARKET FOR OTHER RESEARCH APPLICATIONS,
BY COUNTRY, 2023-2030 (USD MILLION) 141
TABLE 76 SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE,
2023-2030 (USD MILLION) 142
TABLE 77 SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY REGION,
2023-2030 (USD MILLION) 142
TABLE 78 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION) 143
TABLE 79 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS,
BY COUNTRY, 2023-2030 (USD MILLION) 143
TABLE 80 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS,
BY COUNTRY, 2023-2030 (USD MILLION) 144
TABLE 81 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS,
BY COUNTRY, 2023-2030 (USD MILLION) 144
TABLE 82 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS,
BY COUNTRY, 2023-2030 (USD MILLION) 144
TABLE 83 GCC: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION) 145
TABLE 84 SINGLE-CELL ANALYSIS MARKET FOR NON-INVASIVE PRENATAL DIAGNOSIS,
BY REGION, 2023-2030 (USD MILLION) 146
TABLE 85 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR NON-INVASIVE PRENATAL DIAGNOSIS, BY COUNTRY, 2023-2030 (USD MILLION) 146
TABLE 86 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR NON-INVASIVE PRENATAL DIAGNOSIS, BY COUNTRY, 2023-2030 (USD MILLION) 147
TABLE 87 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR NON-INVASIVE PRENATAL DIAGNOSIS, BY COUNTRY, 2023-2030 (USD MILLION) 147
TABLE 88 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR NON-INVASIVE PRENATAL DIAGNOSIS, BY COUNTRY, 2023-2030 (USD MILLION) 148
TABLE 89 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR NON-INVASIVE PRENATAL DIAGNOSIS, BY COUNTRY, 2023-2030 (USD MILLION) 148
TABLE 90 GCC: SINGLE-CELL ANALYSIS MARKET FOR NON-INVASIVE PRENATAL DIAGNOSIS, BY COUNTRY, 2023-2030 (USD MILLION) 148
TABLE 91 SINGLE-CELL ANALYSIS MARKET FOR IN VITRO FERTILIZATION, BY REGION,
2023-2030 (USD MILLION) 149
TABLE 92 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR IN VITRO FERTILIZATION, BY COUNTRY, 2023-2030 (USD MILLION) 149
TABLE 93 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR IN VITRO FERTILIZATION,
BY COUNTRY, 2023-2030 (USD MILLION) 150
TABLE 94 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR IN VITRO FERTILIZATION,
BY COUNTRY, 2023-2030 (USD MILLION) 150
TABLE 95 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR IN VITRO FERTILIZATION,
BY COUNTRY, 2023-2030 (USD MILLION) 151
TABLE 96 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR IN VITRO FERTILIZATION,
BY COUNTRY, 2023-2030 (USD MILLION) 151
TABLE 97 GCC: SINGLE-CELL ANALYSIS MARKET FOR IN VITRO FERTILIZATION, BY COUNTRY, 2023-2030 (USD MILLION) 151
TABLE 98 SINGLE-CELL ANALYSIS MARKET FOR CIRCULATING TUMOR CELL DETECTION,
BY REGION, 2023-2030 (USD MILLION) 152
TABLE 99 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CIRCULATING TUMOR CELL DETECTION, BY COUNTRY, 2023-2030 (USD MILLION) 152
TABLE 100 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR CIRCULATING TUMOR CELL DETECTION, BY COUNTRY, 2023-2030 (USD MILLION) 153
TABLE 101 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR CIRCULATING TUMOR CELL DETECTION, BY COUNTRY, 2023-2030 (USD MILLION) 153
TABLE 102 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CIRCULATING TUMOR CELL DETECTION, BY COUNTRY, 2023-2030 (USD MILLION) 154
TABLE 103 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR CIRCULATING TUMOR CELL DETECTION, BY COUNTRY, 2023-2030 (USD MILLION) 154
TABLE 104 GCC: SINGLE-CELL ANALYSIS MARKET FOR CIRCULATING TUMOR CELL DETECTION, BY COUNTRY, 2023-2030 (USD MILLION) 154
TABLE 105 SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023-2030 (USD MILLION) 156
TABLE 106 SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS, BY REGION,
2023-2030 (USD MILLION) 157
TABLE 107 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS,
BY COUNTRY, 2023-2030 (USD MILLION) 157
TABLE 108 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS, BY COUNTRY, 2023-2030 (USD MILLION) 158
TABLE 109 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS, BY COUNTRY, 2023-2030 (USD MILLION) 158
TABLE 110 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS,
BY COUNTRY, 2023-2030 (USD MILLION) 158
TABLE 111 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS, BY COUNTRY, 2023-2030 (USD MILLION) 159
TABLE 112 GCC: SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS, BY COUNTRY,
2023-2030 (USD MILLION) 159
TABLE 113 SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS, BY REGION,
2023-2030 (USD MILLION) 160
TABLE 114 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS,
BY COUNTRY, 2023-2030 (USD MILLION) 160
TABLE 115 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS, BY COUNTRY, 2023-2030 (USD MILLION) 161
TABLE 116 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS,
BY COUNTRY, 2023-2030 (USD MILLION) 161
TABLE 117 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS,
BY COUNTRY, 2023-2030 (USD MILLION) 161
TABLE 118 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS, BY COUNTRY, 2023-2030 (USD MILLION) 162
TABLE 119 GCC: SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS, BY COUNTRY,
2023-2030 (USD MILLION) 162
TABLE 120 SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS, BY REGION,
2023-2030 (USD MILLION) 163
TABLE 121 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS,
BY COUNTRY, 2023-2030 (USD MILLION) 163
TABLE 122 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS, BY COUNTRY, 2023-2030 (USD MILLION) 164
TABLE 123 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS,
BY COUNTRY, 2023-2030 (USD MILLION) 164
TABLE 124 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS,
BY COUNTRY, 2023-2030 (USD MILLION) 164
TABLE 125 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS,
BY COUNTRY, 2023-2030 (USD MILLION) 165
TABLE 126 GCC: SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS, BY COUNTRY, 2023-2030 (USD MILLION) 165
TABLE 127 SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023-2030 (USD MILLION) 167
TABLE 128 SINGLE-CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH LABORATORIES,
BY REGION, 2023-2030 (USD MILLION) 168
TABLE 129 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2023-2030 (USD MILLION) 168
TABLE 130 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2023-2030 (USD MILLION) 169
TABLE 131 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2023-2030 (USD MILLION) 169
TABLE 132 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2023-2030 (USD MILLION) 170
TABLE 133 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2023-2030 (USD MILLION) 170
TABLE 134 GCC: SINGLE-CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2023-2030 (USD MILLION) 170
TABLE 135 SINGLE-CELL ANALYSIS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2023-2030 (USD MILLION) 171
TABLE 136 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION) 172
TABLE 137 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION) 172
TABLE 138 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION) 173
TABLE 139 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION) 173
TABLE 140 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION) 173
TABLE 141 GCC: SINGLE-CELL ANALYSIS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION) 174
TABLE 142 SINGLE-CELL ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2023-2030 (USD MILLION) 175
TABLE 143 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023-2030 (USD MILLION) 175
TABLE 144 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023-2030 (USD MILLION) 176
TABLE 145 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023-2030 (USD MILLION) 176
TABLE 146 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023-2030 (USD MILLION) 177
TABLE 147 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023-2030 (USD MILLION) 177
TABLE 148 GCC: SINGLE-CELL ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023-2030 (USD MILLION) 177
TABLE 149 SINGLE-CELL ANALYSIS MARKET FOR CELL BANKS & IVF CENTERS, BY REGION, 2023-2030 (USD MILLION) 178
TABLE 150 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CELL BANKS & IVF CENTERS, BY COUNTRY, 2023-2030 (USD MILLION) 179
TABLE 151 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR CELL BANKS & IVF CENTERS,
BY COUNTRY, 2023-2030 (USD MILLION) 179
TABLE 152 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR CELL BANKS & IVF CENTERS, BY COUNTRY, 2023-2030 (USD MILLION) 180
TABLE 153 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CELL BANKS & IVF CENTERS, BY COUNTRY, 2023-2030 (USD MILLION) 180
TABLE 154 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR CELL BANKS & IVF CENTERS, BY COUNTRY, 2023-2030 (USD MILLION) 180
TABLE 155 GCC: SINGLE-CELL ANALYSIS MARKET FOR CELL BANKS & IVF CENTERS,
BY COUNTRY, 2023-2030 (USD MILLION) 181
TABLE 156 SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION) 183
TABLE 157 SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE,
2023-2030 (USD MILLION) 183
TABLE 158 SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY REGION,
2023-2030 (USD MILLION) 184
TABLE 159 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES,
BY COUNTRY, 2023-2030 (USD MILLION) 184
TABLE 160 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY COUNTRY, 2023-2030 (USD MILLION) 184
TABLE 161 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY COUNTRY, 2023-2030 (USD MILLION) 185
TABLE 162 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES,
BY COUNTRY, 2023-2030 (USD MILLION) 185
TABLE 163 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES,
BY COUNTRY, 2023-2030 (USD MILLION) 185
TABLE 164 GCC: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY COUNTRY,
2023-2030 (USD MILLION) 186
TABLE 165 SINGLE-CELL ANALYSIS MARKET FOR BEADS, BY REGION,
2023-2030 (USD MILLION) 187
TABLE 166 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR BEADS, BY COUNTRY, 2023-2030 (USD MILLION) 187
TABLE 167 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR BEADS, BY COUNTRY,
2023-2030 (USD MILLION) 187
TABLE 168 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR BEADS, BY COUNTRY,
2023-2030 (USD MILLION) 188
TABLE 169 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR BEADS, BY COUNTRY, 2023-2030 (USD MILLION) 188
TABLE 170 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR BEADS, BY COUNTRY,
2023-2030 (USD MILLION) 188
TABLE 171 GCC: SINGLE-CELL ANALYSIS MARKET FOR BEADS, BY COUNTRY,
2023-2030 (USD MILLION) 189
TABLE 172 SINGLE-CELL ANALYSIS MARKET FOR MICROPLATES, BY REGION,
2023-2030 (USD MILLION) 190
TABLE 173 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROPLATES,
BY COUNTRY, 2023-2030 (USD MILLION) 190
TABLE 174 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MICROPLATES, BY COUNTRY, 2023-2030 (USD MILLION) 190
TABLE 175 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MICROPLATES, BY COUNTRY, 2023-2030 (USD MILLION) 191
TABLE 176 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROPLATES,
BY COUNTRY, 2023-2030 (USD MILLION) 191
TABLE 177 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MICROPLATES, BY COUNTRY, 2023-2030 (USD MILLION) 191
TABLE 178 GCC: SINGLE-CELL ANALYSIS MARKET FOR MICROPLATES, BY COUNTRY,
2023-2030 (USD MILLION) 192
TABLE 179 SINGLE-CELL ANALYSIS MARKET FOR REAGENTS, BY REGION,
2023-2030 (USD MILLION) 192
TABLE 180 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION) 193
TABLE 181 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR REAGENTS, BY COUNTRY,
2023-2030 (USD MILLION) 193
TABLE 182 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION) 193
TABLE 183 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION) 194
TABLE 184 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION) 194
TABLE 185 GCC: SINGLE-CELL ANALYSIS MARKET FOR REAGENTS, BY COUNTRY,
2023-2030 (USD MILLION) 194
TABLE 186 SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE,
2023-2030 (USD MILLION) 195
TABLE 187 SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY REGION,
2023-2030 (USD MILLION) 195
TABLE 188 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY COUNTRY, 2023-2030 (USD MILLION) 196
TABLE 189 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY COUNTRY,
2023-2030 (USD MILLION) 196
TABLE 190 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY COUNTRY, 2023-2030 (USD MILLION) 196
TABLE 191 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY COUNTRY, 2023-2030 (USD MILLION) 197
TABLE 192 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY COUNTRY, 2023-2030 (USD MILLION) 197
TABLE 193 GCC: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY COUNTRY,
2023-2030 (USD MILLION) 197
TABLE 194 SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR IMMUNOASSAYS, BY REGION, 2023-2030 (USD MILLION) 198
TABLE 195 NORTH AMERICA: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2023-2030 (USD MILLION) 198
TABLE 196 EUROPE: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR IMMUNOASSAYS,
BY COUNTRY, 2023-2030 (USD MILLION) 199
TABLE 197 ASIA PACIFIC: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2023-2030 (USD MILLION) 199
TABLE 198 LATIN AMERICA: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2023-2030 (USD MILLION) 199
TABLE 199 MIDDLE EAST: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2023-2030 (USD MILLION) 200
TABLE 200 GCC: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR IMMUNOASSAYS,
BY COUNTRY, 2023-2030 (USD MILLION) 200
TABLE 201 SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR CELL-BASED ASSAYS,
BY REGION, 2023-2030 (USD MILLION) 201
TABLE 202 NORTH AMERICA: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2023-2030 (USD MILLION) 201
TABLE 203 EUROPE: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2023-2030 (USD MILLION) 201
TABLE 204 ASIA PACIFIC: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2023-2030 (USD MILLION) 202
TABLE 205 LATIN AMERICA: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2023-2030 (USD MILLION) 202
TABLE 206 MIDDLE EAST: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2023-2030 (USD MILLION) 202
TABLE 207 GCC: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR CELL-BASED ASSAYS,
BY COUNTRY, 2023-2030 (USD MILLION) 203
TABLE 208 SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES, BY REGION,
2023-2030 (USD MILLION) 203
TABLE 209 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES,
BY COUNTRY, 2023-2030 (USD MILLION) 204
TABLE 210 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES,
BY COUNTRY, 2023-2030 (USD MILLION) 204
TABLE 211 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES,
BY COUNTRY, 2023-2030 (USD MILLION) 204
TABLE 212 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES,
BY COUNTRY, 2023-2030 (USD MILLION) 205
TABLE 213 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES,
BY COUNTRY, 2023-2030 (USD MILLION) 205
TABLE 214 GCC: SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2023-2030 (USD MILLION) 205
TABLE 215 SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE,
2023-2030 (USD MILLION) 206
TABLE 216 SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY REGION,
2023-2030 (USD MILLION) 207
TABLE 217 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS,
BY COUNTRY, 2023-2030 (USD MILLION) 207
TABLE 218 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2023-2030 (USD MILLION) 207
TABLE 219 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2023-2030 (USD MILLION) 208
TABLE 220 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS,
BY COUNTRY, 2023-2030 (USD MILLION) 208
TABLE 221 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2023-2030 (USD MILLION) 208
TABLE 222 GCC: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY,
2023-2030 (USD MILLION) 209
TABLE 223 SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETERS, BY REGION,
2023-2030 (USD MILLION) 210
TABLE 224 NORTH AMERICA: SINGLE-CELL ANALYSIS FLOW CYTOMETERS MARKET,
BY COUNTRY, 2023-2030 (USD MILLION) 211
TABLE 225 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETERS, BY COUNTRY, 2023-2030 (USD MILLION) 211
TABLE 226 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETERS,
BY COUNTRY, 2023-2030 (USD MILLION) 211
TABLE 227 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETERS,
BY COUNTRY, 2023-2030 (USD MILLION) 212
TABLE 228 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETERS,
BY COUNTRY, 2023-2030 (USD MILLION) 212
TABLE 229 GCC: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETERS, BY COUNTRY, 2023-2030 (USD MILLION) 212
TABLE 230 SINGLE-CELL ANALYSIS MARKET FOR NGS SYSTEMS, BY REGION,
2023-2030 (USD MILLION) 213
TABLE 231 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR NGS SYSTEMS,
BY COUNTRY, 2023-2030 (USD MILLION) 214
TABLE 232 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR NGS SYSTEMS, BY COUNTRY, 2023-2030 (USD MILLION) 214
TABLE 233 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR NGS SYSTEMS, BY COUNTRY, 2023-2030 (USD MILLION) 214
TABLE 234 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR NGS SYSTEMS,
BY COUNTRY, 2023-2030 (USD MILLION) 215
TABLE 235 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR NGS SYSTEMS, BY COUNTRY, 2023-2030 (USD MILLION) 215
TABLE 236 GCC: SINGLE-CELL ANALYSIS MARKET FOR NGS SYSTEMS, BY COUNTRY,
2023-2030 (USD MILLION) 215
TABLE 237 SINGLE-CELL ANALYSIS MARKET FOR PCR INSTRUMENTS, BY REGION,
2023-2030 (USD MILLION) 216
TABLE 238 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR PCR INSTRUMENTS,
BY COUNTRY, 2023-2030 (USD MILLION) 216
TABLE 239 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR PCR INSTRUMENTS, BY COUNTRY, 2023-2030 (USD MILLION) 217
TABLE 240 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR PCR INSTRUMENTS,
BY COUNTRY, 2023-2030 (USD MILLION) 217
TABLE 241 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR PCR INSTRUMENTS,
BY COUNTRY, 2023-2030 (USD MILLION) 217
TABLE 242 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR PCR INSTRUMENTS,
BY COUNTRY, 2023-2030 (USD MILLION) 218
TABLE 243 GCC: SINGLE-CELL ANALYSIS MARKET FOR PCR INSTRUMENTS, BY COUNTRY, 2023-2030 (USD MILLION) 218
TABLE 244 SINGLE-CELL ANALYSIS MARKET FOR SPECTROPHOTOMETERS, BY REGION, 2023-2030 (USD MILLION) 219
TABLE 245 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR SPECTROPHOTOMETERS, BY COUNTRY, 2023-2030 (USD MILLION) 219
TABLE 246 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR SPECTROPHOTOMETERS,
BY COUNTRY, 2023-2030 (USD MILLION) 219
TABLE 247 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR SPECTROPHOTOMETERS,
BY COUNTRY, 2023-2030 (USD MILLION) 220
TABLE 248 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR SPECTROPHOTOMETERS, BY COUNTRY, 2023-2030 (USD MILLION) 220
TABLE 249 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR SPECTROPHOTOMETERS,
BY COUNTRY, 2023-2030 (USD MILLION) 220
TABLE 250 GCC: SINGLE-CELL ANALYSIS MARKET FOR SPECTROPHOTOMETERS, BY COUNTRY, 2023-2030 (USD MILLION) 221
TABLE 251 SINGLE-CELL ANALYSIS MARKET FOR CELL COUNTERS, BY REGION,
2023-2030 (USD MILLION) 222
TABLE 252 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CELL COUNTERS,
BY COUNTRY, 2023-2030 (USD MILLION) 222
TABLE 253 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR CELL COUNTERS, BY COUNTRY, 2023-2030 (USD MILLION) 222
TABLE 254 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR CELL COUNTERS,
BY COUNTRY, 2023-2030 (USD MILLION) 223
TABLE 255 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CELL COUNTERS,
BY COUNTRY, 2023-2030 (USD MILLION) 223
TABLE 256 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR CELL COUNTERS,
BY COUNTRY, 2023-2030 (USD MILLION) 223
TABLE 257 GCC: SINGLE-CELL ANALYSIS MARKET FOR CELL COUNTERS, BY COUNTRY,
2023-2030 (USD MILLION) 224
TABLE 258 SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPES, BY REGION,
2023-2030 (USD MILLION) 224
TABLE 259 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPES,
BY COUNTRY, 2023-2030 (USD MILLION) 225
TABLE 260 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPES, BY COUNTRY, 2023-2030 (USD MILLION) 225
TABLE 261 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPES, BY COUNTRY, 2023-2030 (USD MILLION) 225
TABLE 262 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPES,
BY COUNTRY, 2023-2030 (USD MILLION) 226
TABLE 263 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPES, BY COUNTRY, 2023-2030 (USD MILLION) 226
TABLE 264 GCC: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPES, BY COUNTRY,
2023-2030 (USD MILLION) 226
TABLE 265 SINGLE-CELL ANALYSIS MARKET FOR HCS SYSTEMS, BY REGION,
2023-2030 (USD MILLION) 227
TABLE 266 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR HCS SYSTEMS,
BY COUNTRY, 2023-2030 (USD MILLION) 227
TABLE 267 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR HCS SYSTEMS, BY COUNTRY, 2023-2030 (USD MILLION) 228
TABLE 268 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR HCS SYSTEMS, BY COUNTRY, 2023-2030 (USD MILLION) 228
TABLE 269 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR HCS SYSTEMS,
BY COUNTRY, 2023-2030 (USD MILLION) 228
TABLE 270 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR HCS SYSTEMS, BY COUNTRY, 2023-2030 (USD MILLION) 229
TABLE 271 GCC: SINGLE-CELL ANALYSIS MARKET FOR HCS SYSTEMS, BY COUNTRY,
2023-2030 (USD MILLION) 229
TABLE 272 SINGLE-CELL ANALYSIS MARKET FOR MICROARRAYS, BY REGION,
2023-2030 (USD MILLION) 230
TABLE 273 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROARRAYS,
BY COUNTRY, 2023-2030 (USD MILLION) 230
TABLE 274 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MICROARRAYS, BY COUNTRY, 2023-2030 (USD MILLION) 231
TABLE 275 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MICROARRAYS, BY COUNTRY, 2023-2030 (USD MILLION) 231
TABLE 276 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROARRAYS,
BY COUNTRY, 2023-2030 (USD MILLION) 231
TABLE 277 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MICROARRAYS,
BY COUNTRY, 2023-2030 (USD MILLION) 232
TABLE 278 GCC: SINGLE-CELL ANALYSIS MARKET FOR MICROARRAYS, BY COUNTRY,
2023-2030 (USD MILLION) 232
TABLE 279 SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY REGION,
2023-2030 (USD MILLION) 233
TABLE 280 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS,
BY COUNTRY, 2023-2030 (USD MILLION) 233
TABLE 281 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS,
BY COUNTRY, 2023-2030 (USD MILLION) 233
TABLE 282 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS,
BY COUNTRY, 2023-2030 (USD MILLION) 234
TABLE 283 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS,
BY COUNTRY, 2023-2030 (USD MILLION) 234
TABLE 284 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS,
BY COUNTRY, 2023-2030 (USD MILLION) 234
TABLE 285 GCC: SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2023-2030 (USD MILLION) 235
TABLE 286 SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023-2030 (USD MILLION) 237
TABLE 287 SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY REGION,
2023-2030 (USD MILLION) 238
TABLE 288 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY,
BY COUNTRY, 2023-2030 (USD MILLION) 238
TABLE 289 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY,
BY COUNTRY, 2023-2030 (USD MILLION) 239
TABLE 290 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY,
BY COUNTRY, 2023-2030 (USD MILLION) 239
TABLE 291 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY,
BY COUNTRY, 2023-2030 (USD MILLION) 240
TABLE 292 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY,
BY COUNTRY, 2023-2030 (USD MILLION) 240
TABLE 293 GCC: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2023-2030 (USD MILLION) 240
TABLE 294 SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING,
BY REGION, 2023-2030 (USD MILLION) 241
TABLE 295 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2023-2030 (USD MILLION) 242
TABLE 296 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2023-2030 (USD MILLION) 242
TABLE 297 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2023-2030 (USD MILLION) 243
TABLE 298 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2023-2030 (USD MILLION) 243
TABLE 299 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2023-2030 (USD MILLION) 243
TABLE 300 GCC: SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING,
BY COUNTRY, 2023-2030 (USD MILLION) 244
TABLE 301 SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION, BY REGION, 2023-2030 (USD MILLION) 245
TABLE 302 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2023-2030 (USD MILLION) 245
TABLE 303 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION,
BY COUNTRY, 2023-2030 (USD MILLION) 245

TABLE 304 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2023-2030 (USD MILLION) 246
TABLE 305 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2023-2030 (USD MILLION) 246
TABLE 306 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2023-2030 (USD MILLION) 246
TABLE 307 GCC: SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION,
BY COUNTRY, 2023-2030 (USD MILLION) 247
TABLE 308 SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY REGION,
2023-2030 (USD MILLION) 247
TABLE 309 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY,
BY COUNTRY, 2023-2030 (USD MILLION) 248
TABLE 310 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY, 2023-2030 (USD MILLION) 248
TABLE 311 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY, 2023-2030 (USD MILLION) 248
TABLE 312 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY, 2023-2030 (USD MILLION) 249
TABLE 313 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY, 2023-2030 (USD MILLION) 249
TABLE 314 GCC: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY,
2023-2030 (USD MILLION) 249
TABLE 315 SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY, BY REGION,
2023-2030 (USD MILLION) 250
TABLE 316 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY,
BY COUNTRY, 2023-2030 (USD MILLION) 250
TABLE 317 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY,
BY COUNTRY, 2023-2030 (USD MILLION) 251
TABLE 318 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY,
BY COUNTRY, 2023-2030 (USD MILLION) 251
TABLE 319 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY,
BY COUNTRY, 2023-2030 (USD MILLION) 252
TABLE 320 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY,
BY COUNTRY, 2023-2030 (USD MILLION) 252
TABLE 321 GCC: SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY, BY COUNTRY, 2023-2030 (USD MILLION) 252
TABLE 322 SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY REGION,
2023-2030 (USD MILLION) 254
TABLE 323 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES,
BY COUNTRY, 2023-2030 (USD MILLION) 254
TABLE 324 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2023-2030 (USD MILLION) 254
TABLE 325 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES,
BY COUNTRY, 2023-2030 (USD MILLION) 255
TABLE 326 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES,
BY COUNTRY, 2023-2030 (USD MILLION) 255
TABLE 327 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES,
BY COUNTRY, 2023-2030 (USD MILLION) 256
TABLE 328 GCC: SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2023-2030 (USD MILLION) 256
TABLE 329 SINGLE-CELL ANALYSIS MARKET, BY REGION, 2023-2030 (USD MILLION) 258
TABLE 330 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 259
TABLE 331 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT,
2023-2030 (USD MILLION) 260
TABLE 332 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023-2030 (USD MILLION) 260
TABLE 333 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023-2030 (USD MILLION) 260
TABLE 334 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION) 261
TABLE 335 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE,
2023-2030 (USD MILLION) 261
TABLE 336 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE,
2023-2030 (USD MILLION) 262
TABLE 337 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 262
TABLE 338 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION) 262
TABLE 339 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION) 263
TABLE 340 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY END USER,
2023-2030 (USD MILLION) 263
TABLE 341 NORTH AMERICA: MACROECONOMIC INDICATORS 264
TABLE 342 US: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION) 265
TABLE 343 US: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE,
2023-2030 (USD MILLION) 266
TABLE 344 US: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE,
2023-2030 (USD MILLION) 266
TABLE 345 US: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE,
2023-2030 (USD MILLION) 267
TABLE 346 US: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023-2030 (USD MILLION) 267
TABLE 347 US: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023-2030 (USD MILLION) 268
TABLE 348 US: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 268
TABLE 349 US: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION) 268
TABLE 350 US: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION) 269
TABLE 351 US: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023-2030 (USD MILLION) 269
TABLE 352 CANADA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT,
2023-2030 (USD MILLION) 270
TABLE 353 CANADA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE,
2023-2030 (USD MILLION) 270
TABLE 354 CANADA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE,
2023-2030 (USD MILLION) 270
TABLE 355 CANADA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE,
2023-2030 (USD MILLION) 271
TABLE 356 CANADA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE,
2023-2030 (USD MILLION) 271
TABLE 357 CANADA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE,
2023-2030 (USD MILLION) 272
TABLE 358 CANADA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 272
TABLE 359 CANADA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS,
BY TYPE, 2023-2030 (USD MILLION) 272
TABLE 360 CANADA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION) 273
TABLE 361 CANADA: SINGLE-CELL ANALYSIS MARKET, BY END USER,
2023-2030 (USD MILLION) 273
TABLE 362 EUROPE: SINGLE-CELL ANALYSIS MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 274
TABLE 363 EUROPE: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT,
2023-2030 (USD MILLION) 274
TABLE 364 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE,
2023-2030 (USD MILLION) 274
TABLE 365 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE,
2023-2030 (USD MILLION) 275
TABLE 366 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE,
2023-2030 (USD MILLION) 275
TABLE 367 EUROPE: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE,
2023-2030 (USD MILLION) 275
TABLE 368 EUROPE: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE,
2023-2030 (USD MILLION) 276
TABLE 369 EUROPE: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 276
TABLE 370 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS,
BY TYPE, 2023-2030 (USD MILLION) 276
TABLE 371 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS,
BY TYPE, 2023-2030 (USD MILLION) 277
TABLE 372 EUROPE: SINGLE-CELL ANALYSIS MARKET, BY END USER,
2023-2030 (USD MILLION) 277
TABLE 373 EUROPE: MACROECONOMIC INDICATORS 278
TABLE 374 GERMANY: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT,
2023-2030 (USD MILLION) 279
TABLE 375 GERMANY: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE,
2023-2030 (USD MILLION) 279
TABLE 376 GERMANY: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE,
2023-2030 (USD MILLION) 279
TABLE 377 GERMANY: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE,
2023-2030 (USD MILLION) 280
TABLE 378 GERMANY: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE,
2023-2030 (USD MILLION) 280
TABLE 379 GERMANY: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE,
2023-2030 (USD MILLION) 281
TABLE 380 GERMANY: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 281
TABLE 381 GERMANY: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS,
BY TYPE, 2023-2030 (USD MILLION) 281
TABLE 382 GERMANY: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS,
BY TYPE, 2023-2030 (USD MILLION) 282
TABLE 383 GERMANY: SINGLE-CELL ANALYSIS MARKET, BY END USER,
2023-2030 (USD MILLION) 282
TABLE 384 UK: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION) 283
TABLE 385 UK: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE,
2023-2030 (USD MILLION) 283
TABLE 386 UK: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE,
2023-2030 (USD MILLION) 283
TABLE 387 UK: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE,
2023-2030 (USD MILLION) 284
TABLE 388 UK: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023-2030 (USD MILLION) 284
TABLE 389 UK: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023-2030 (USD MILLION) 285
TABLE 390 UK: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 285
TABLE 391 UK: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS,
BY TYPE, 2023-2030 (USD MILLION) 285
TABLE 392 UK: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS,
BY TYPE, 2023-2030 (USD MILLION) 286
TABLE 393 UK: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023-2030 (USD MILLION) 286
TABLE 394 FRANCE: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT,
2023-2030 (USD MILLION) 287
TABLE 395 FRANCE: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES,
BY TYPE, 2023-2030 (USD MILLION) 287
TABLE 396 FRANCE: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE,
2023-2030 (USD MILLION) 287
TABLE 397 FRANCE: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE,
2023-2030 (USD MILLION) 288
TABLE 398 FRANCE: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE,
2023-2030 (USD MILLION) 288
TABLE 399 FRANCE: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE,
2023-2030 (USD MILLION) 289
TABLE 400 FRANCE: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 289
TABLE 401 FRANCE: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS,
BY TYPE, 2023-2030 (USD MILLION) 289
TABLE 402 FRANCE: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS,
BY TYPE, 2023-2030 (USD MILLION) 290
TABLE 403 FRANCE: SINGLE-CELL ANALYSIS MARKET, BY END USER,
2023-2030 (USD MILLION) 290
TABLE 404 ITALY: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION) 291
TABLE 405 ITALY: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE,
2023-2030 (USD MILLION) 291
TABLE 406 ITALY: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE,
2023-2030 (USD MILLION) 291
TABLE 407 ITALY: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE,
2023-2030 (USD MILLION) 292
TABLE 408 ITALY: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE,
2023-2030 (USD MILLION) 292
TABLE 409 ITALY: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE,
2023-2030 (USD MILLION) 293
TABLE 410 ITALY: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 293
TABLE 411 ITALY: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION) 293
TABLE 412 ITALY: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS,
BY TYPE, 2023-2030 (USD MILLION) 294
TABLE 413 ITALY: SINGLE-CELL ANALYSIS MARKET, BY END USER,
2023-2030 (USD MILLION) 294
TABLE 414 SPAIN: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT,
2023-2030 (USD MILLION) 295
TABLE 415 SPAIN: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE,
2023-2030 (USD MILLION) 295
TABLE 416 SPAIN: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE,
2023-2030 (USD MILLION) 295
TABLE 417 SPAIN: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE,
2023-2030 (USD MILLION) 296
TABLE 418 SPAIN: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE,
2023-2030 (USD MILLION) 296
TABLE 419 SPAIN: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE,
2023-2030 (USD MILLION) 297
TABLE 420 SPAIN: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 297
TABLE 421 SPAIN: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS,
BY TYPE, 2023-2030 (USD MILLION) 297
TABLE 422 SPAIN: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS,
BY TYPE, 2023-2030 (USD MILLION) 298
TABLE 423 SPAIN: SINGLE-CELL ANALYSIS MARKET, BY END USER,
2023-2030 (USD MILLION) 298
TABLE 424 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT,
2023-2030 (USD MILLION) 299
TABLE 425 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES,
BY TYPE, 2023-2030 (USD MILLION) 299
TABLE 426 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023-2030 (USD MILLION) 299
TABLE 427 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION) 300
TABLE 428 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE,
2023-2030 (USD MILLION) 300
TABLE 429 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE,
2023-2030 (USD MILLION) 301
TABLE 430 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 301
TABLE 431 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION) 301
TABLE 432 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION) 302
TABLE 433 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET, BY END USER,
2023-2030 (USD MILLION) 302
TABLE 434 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 305
TABLE 435 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT,
2023-2030 (USD MILLION) 305
TABLE 436 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023-2030 (USD MILLION) 305
TABLE 437 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE,
2023-2030 (USD MILLION) 306
TABLE 438 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION) 306
TABLE 439 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE,
2023-2030 (USD MILLION) 306
TABLE 440 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE,
2023-2030 (USD MILLION) 307
TABLE 441 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 307
TABLE 442 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS,
BY TYPE, 2023-2030 (USD MILLION) 307
TABLE 443 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS,
BY TYPE, 2023-2030 (USD MILLION) 308
TABLE 444 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY END USER,
2023-2030 (USD MILLION) 308
TABLE 445 ASIA PACIFIC: MACROECONOMIC INDICATORS 309
TABLE 446 CHINA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT,
2023-2030 (USD MILLION) 310
TABLE 447 CHINA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE,
2023-2030 (USD MILLION) 310
TABLE 448 CHINA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE,
2023-2030 (USD MILLION) 310
TABLE 449 CHINA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE,
2023-2030 (USD MILLION) 311
TABLE 450 CHINA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE,
2023-2030 (USD MILLION) 311
TABLE 451 CHINA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE,
2023-2030 (USD MILLION) 312
TABLE 452 CHINA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 312
TABLE 453 CHINA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS,
BY TYPE, 2023-2030 (USD MILLION) 312
TABLE 454 CHINA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS,
BY TYPE, 2023-2030 (USD MILLION) 313
TABLE 455 CHINA: SINGLE-CELL ANALYSIS MARKET, BY END USER,
2023-2030 (USD MILLION) 313
TABLE 456 JAPAN: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT,
2023-2030 (USD MILLION) 314
TABLE 457 JAPAN: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE,
2023-2030 (USD MILLION) 314
TABLE 458 JAPAN: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE,
2023-2030 (USD MILLION) 314
TABLE 459 JAPAN: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE,
2023-2030 (USD MILLION) 315
TABLE 460 JAPAN: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE,
2023-2030 (USD MILLION) 315
TABLE 461 JAPAN: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE,
2023-2030 (USD MILLION) 316
TABLE 462 JAPAN: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 316
TABLE 463 JAPAN: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION) 316
TABLE 464 JAPAN: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION) 317
TABLE 465 JAPAN: SINGLE-CELL ANALYSIS MARKET, BY END USER,
2023-2030 (USD MILLION) 317
TABLE 466 INDIA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION) 318
TABLE 467 INDIA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE,
2023-2030 (USD MILLION) 318
TABLE 468 INDIA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE,
2023-2030 (USD MILLION) 318
TABLE 469 INDIA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE,
2023-2030 (USD MILLION) 319
TABLE 470 INDIA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE,
2023-2030 (USD MILLION) 319
TABLE 471 INDIA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE,
2023-2030 (USD MILLION) 320
TABLE 472 INDIA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 320
TABLE 473 INDIA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION) 320
TABLE 474 INDIA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION) 321
TABLE 475 INDIA: SINGLE-CELL ANALYSIS MARKET, BY END USER,
2023-2030 (USD MILLION) 321
TABLE 476 SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT,
2023-2030 (USD MILLION) 322
TABLE 477 SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023-2030 (USD MILLION) 322
TABLE 478 SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE,
2023-2030 (USD MILLION) 322
TABLE 479 SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION) 323
TABLE 480 SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE,
2023-2030 (USD MILLION) 323
TABLE 481 SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE,
2023-2030 (USD MILLION) 324
TABLE 482 SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 324
TABLE 483 SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION) 324
TABLE 484 SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS,
BY TYPE, 2023-2030 (USD MILLION) 325
TABLE 485 SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET, BY END USER,
2023-2030 (USD MILLION) 325
TABLE 486 AUSTRALIA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT,
2023-2030 (USD MILLION) 326
TABLE 487 AUSTRALIA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023-2030 (USD MILLION) 326
TABLE 488 AUSTRALIA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE,
2023-2030 (USD MILLION) 326
TABLE 489 AUSTRALIA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE,
2023-2030 (USD MILLION) 327
TABLE 490 AUSTRALIA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE,
2023-2030 (USD MILLION) 327
TABLE 491 AUSTRALIA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE,
2023-2030 (USD MILLION) 328
TABLE 492 AUSTRALIA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 328
TABLE 493 AUSTRALIA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS,
BY TYPE, 2023-2030 (USD MILLION) 328
TABLE 494 AUSTRALIA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS,
BY TYPE, 2023-2030 (USD MILLION) 329
TABLE 495 AUSTRALIA: SINGLE-CELL ANALYSIS MARKET, BY END USER,
2023-2030 (USD MILLION) 329
TABLE 496 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT,
2023-2030 (USD MILLION) 330
TABLE 497 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES,
BY TYPE, 2023-2030 (USD MILLION) 330
TABLE 498 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS,
BY TYPE, 2023-2030 (USD MILLION) 330
TABLE 499 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS,
BY TYPE, 2023-2030 (USD MILLION) 331
TABLE 500 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE,
2023-2030 (USD MILLION) 331
TABLE 501 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE,
2023-2030 (USD MILLION) 332
TABLE 502 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 332
TABLE 503 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION) 332
TABLE 504 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION) 333
TABLE 505 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY END USER,
2023-2030 (USD MILLION) 333
TABLE 506 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 334
TABLE 507 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT,
2023-2030 (USD MILLION) 334
TABLE 508 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023-2030 (USD MILLION) 334
TABLE 509 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023-2030 (USD MILLION) 335
TABLE 510 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION) 335
TABLE 511 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE,
2023-2030 (USD MILLION) 335
TABLE 512 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE,
2023-2030 (USD MILLION) 336
TABLE 513 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 336
TABLE 514 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION) 336
TABLE 515 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS,
BY TYPE, 2023-2030 (USD MILLION) 337
TABLE 516 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY END USER,
2023-2030 (USD MILLION) 337
TABLE 517 LATIN AMERICA: MACROECONOMIC INDICATORS 338
TABLE 518 BRAZIL: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT,
2023-2030 (USD MILLION) 338
TABLE 519 BRAZIL: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE,
2023-2030 (USD MILLION) 339
TABLE 520 BRAZIL: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE,
2023-2030 (USD MILLION) 339
TABLE 521 BRAZIL: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE,
2023-2030 (USD MILLION) 340
TABLE 522 BRAZIL: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE,
2023-2030 (USD MILLION) 340
TABLE 523 BRAZIL: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE,
2023-2030 (USD MILLION) 341
TABLE 524 BRAZIL: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 341
TABLE 525 BRAZIL: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION) 341
TABLE 526 BRAZIL: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION) 342
TABLE 527 BRAZIL: SINGLE-CELL ANALYSIS MARKET, BY END USER,
2023-2030 (USD MILLION) 342
TABLE 528 MEXICO: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT,
2023-2030 (USD MILLION) 343
TABLE 529 MEXICO: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE,
2023-2030 (USD MILLION) 343
TABLE 530 MEXICO: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE,
2023-2030 (USD MILLION) 343
TABLE 531 MEXICO: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE,
2023-2030 (USD MILLION) 344
TABLE 532 MEXICO: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE,
2023-2030 (USD MILLION) 344
TABLE 533 MEXICO: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE,
2023-2030 (USD MILLION) 345
TABLE 534 MEXICO: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 345
TABLE 535 MEXICO: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS,
BY TYPE, 2023-2030 (USD MILLION) 345
TABLE 536 MEXICO: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS,
BY TYPE, 2023-2030 (USD MILLION) 346
TABLE 537 MEXICO: SINGLE-CELL ANALYSIS MARKET, BY END USER,
2023-2030 (USD MILLION) 346
TABLE 538 REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT,
2023-2030 (USD MILLION) 347
TABLE 539 REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023-2030 (USD MILLION) 347
TABLE 540 REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS,
BY TYPE, 2023-2030 (USD MILLION) 347
TABLE 541 REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS,
BY TYPE, 2023-2030 (USD MILLION) 348
TABLE 542 REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023-2030 (USD MILLION) 348
TABLE 543 REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE,
2023-2030 (USD MILLION) 349
TABLE 544 REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION) 349
TABLE 545 REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION) 349
TABLE 546 REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION) 350
TABLE 547 REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY END USER,
2023-2030 (USD MILLION) 350
TABLE 548 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 351
TABLE 549 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT,
2023-2030 (USD MILLION) 351
TABLE 550 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023-2030 (USD MILLION) 351
TABLE 551 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE,
2023-2030 (USD MILLION) 352
TABLE 552 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION) 352
TABLE 553 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE,
2023-2030 (USD MILLION) 352
TABLE 554 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE,
2023-2030 (USD MILLION) 353
TABLE 555 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 353
TABLE 556 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS,
BY TYPE, 2023-2030 (USD MILLION) 353
TABLE 557 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS,
BY TYPE, 2023-2030 (USD MILLION) 354
TABLE 558 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY END USER,
2023-2030 (USD MILLION) 354
TABLE 559 MIDDLE EAST: MACROECONOMIC INDICATORS 355
TABLE 560 GCC: SINGLE-CELL ANALYSIS MARKET, BY COUNTRY, 2023-2030 (USD MILLION) 355
TABLE 561 GCC: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION) 356
TABLE 562 GCC: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE,
2023-2030 (USD MILLION) 356
TABLE 563 GCC: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE,
2023-2030 (USD MILLION) 356
TABLE 564 GCC: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE,
2023-2030 (USD MILLION) 357
TABLE 565 GCC: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023-2030 (USD MILLION) 357
TABLE 566 GCC: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE,
2023-2030 (USD MILLION) 358
TABLE 567 GCC: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 358
TABLE 568 GCC: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS,
BY TYPE, 2023-2030 (USD MILLION) 358
TABLE 569 GCC: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS,
BY TYPE, 2023-2030 (USD MILLION) 359
TABLE 570 GCC: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023-2030 (USD MILLION) 359
TABLE 571 SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT,
2023-2030 (USD MILLION) 360
TABLE 572 SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES,
BY TYPE, 2023-2030 (USD MILLION) 360
TABLE 573 SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE,
2023-2030 (USD MILLION) 360
TABLE 574 SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION) 361
TABLE 575 SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE,
2023-2030 (USD MILLION) 361
TABLE 576 SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE,
2023-2030 (USD MILLION) 362
TABLE 577 SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 362
TABLE 578 SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS,
BY TYPE, 2023-2030 (USD MILLION) 362
TABLE 579 SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS,
BY TYPE, 2023-2030 (USD MILLION) 363
TABLE 580 SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET, BY END USER,
2023-2030 (USD MILLION) 363
TABLE 581 UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT,
2023-2030 (USD MILLION) 364
TABLE 582 UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023-2030 (USD MILLION) 364
TABLE 583 UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS,
BY TYPE, 2023-2030 (USD MILLION) 364
TABLE 584 UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS,
BY TYPE, 2023-2030 (USD MILLION) 365
TABLE 585 UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE,
2023-2030 (USD MILLION) 365
TABLE 586 UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE,
2023-2030 (USD MILLION) 366
TABLE 587 UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION) 366
TABLE 588 UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION) 366
TABLE 589 UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION) 367
TABLE 590 UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET, BY END USER,
2023-2030 (USD MILLION) 367
TABLE 591 REST OF GCC: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT,
2023-2030 (USD MILLION) 368
TABLE 592 REST OF GCC: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES,
BY TYPE, 2023-2030 (USD MILLION) 368
TABLE 593 REST OF GCC: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE,
2023-2030 (USD MILLION) 368
TABLE 594 REST OF GCC: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION) 369
TABLE 595 REST OF GCC: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE,
2023-2030 (USD MILLION) 369
TABLE 596 REST OF GCC: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE,
2023-2030 (USD MILLION) 370
TABLE 597 REST OF GCC: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 370
TABLE 598 REST OF GCC: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS,
BY TYPE, 2023-2030 (USD MILLION) 370
TABLE 599 REST OF GCC: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS,
BY TYPE, 2023-2030 (USD MILLION) 371
TABLE 600 REST OF GCC: SINGLE-CELL ANALYSIS MARKET, BY END USER,
2023-2030 (USD MILLION) 371
TABLE 601 REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT,
2023-2030 (USD MILLION) 372
TABLE 602 REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES,
BY TYPE, 2023-2030 (USD MILLION) 372
TABLE 603 REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS,
BY TYPE, 2023-2030 (USD MILLION) 372
TABLE 604 REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS,
BY TYPE, 2023-2030 (USD MILLION) 373
TABLE 605 REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE,
2023-2030 (USD MILLION) 373
TABLE 606 REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE,
2023-2030 (USD MILLION) 374
TABLE 607 REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 374
TABLE 608 REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION) 374
TABLE 609 REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION) 375
TABLE 610 REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY END USER,
2023-2030 (USD MILLION) 375
TABLE 611 AFRICA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT,
2023-2030 (USD MILLION) 376
TABLE 612 AFRICA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE,
2023-2030 (USD MILLION) 376
TABLE 613 AFRICA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE,
2023-2030 (USD MILLION) 377
TABLE 614 AFRICA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS,
BY TYPE, 2023-2030 (USD MILLION) 377
TABLE 615 AFRICA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE,
2023-2030 (USD MILLION) 377
TABLE 616 AFRICA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE,
2023-2030 (USD MILLION) 378
TABLE 617 AFRICA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 378
TABLE 618 AFRICA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS,
BY TYPE, 2023-2030 (USD MILLION) 378
TABLE 619 AFRICA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS,
BY TYPE, 2023-2030 (USD MILLION) 379
TABLE 620 AFRICA: SINGLE-CELL ANALYSIS MARKET, BY END USER,
2023-2030 (USD MILLION) 379
TABLE 621 MACROECONOMIC OUTLOOK FOR AFRICA 380

  • Not Sure / Need Reassuring
    • Confirm Content
      • Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:

        Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.

        Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.

        Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.

    • Sample Pages
      • With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.

        It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.

        To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Check for Alternatives
      • Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.

        To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.

  • Prices / Formats / Delivery
    • Prices
      • All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.

        Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Discounts
      • As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.

        Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.

        To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Available Currencies
      • Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.

        Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.

        To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.

    • Licenses
      • License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Global Site License
      • The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.

        It is important to note that this may exclude Parent Companies or Subsidiaries.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Formats
      • The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.

        If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.

    • Delivery
      • Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.

        Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.

        If a delay in delivery is expected you will be informed about it immediately.

    • Shipping Charges
      • As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.

        If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.

  • Ordering
    • By Credit Card
      • We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.

        Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.

        For more information on PayU please visit: https://www.payu.pl/en/about-us

    • By Money Transfer
      • If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.

        With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.

  • Security
    • Website security
      • We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.

        Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.

    • Credit Card Security
      • We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.

        PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.

PLEASE SELECT LICENSE
  • $4950.00
  • $6650.00
  • $8150.00
  • $10000.00
  • ADD TO BASKET
  • BUY NOW